Q91.1
Trisomy 18, mosaicism (mitotic nondisjunction)
Clinical Classification Guidelines
Medical Intelligence & Overview
Trisomy 18 mosaicism, also known as Edwards syndrome, is a genetic condition where some cells in the body have an extra copy of chromosome 18, while others have the usual two copies. This mosaic pattern results from a process called mitotic nondisjunction, leading to a mixture of normal and affected cells. The condition can vary significantly in severity and features, depending on the distribution and proportion of abnormal cells.
Causes & Symptoms
Clinical Causes: Mitotic nondisjunction during early cell division after conception, leading to some cells with an extra chromosome 18 Genetic mosaicism resulting from post-zygotic errors, which are not inherited but occur during early embryonic development
Key Symptoms: Low birth weight and growth delays Distinctive facial features such as a small head, a prominent forehead, and low-set ears Heart defects, including ventricular septal defects and patent ductus arteriosus Clenched fists with overlapping fingers Low muscle tone (hypotonia) Developmental delays and intellectual disabilities Malformed organs and structural abnormalities Seizures or neurological issues in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of physical examinations and genetic testing. Chromosomal analysis methods like karyotyping can detect the presence of extra chromosome 18 in affected cells. Additionally, more advanced techniques such as fluorescence in situ hybridization (FISH) or chromosomal microarray analysis may help determine the mosaic nature of the condition. Prenatal screening and diagnostic procedures, including ultrasound and amniocentesis, can sometimes identify signs of trisomy 18 before birth.
Treatment Protocols: There is no cure for mosaic trisomy 18. Management focuses on addressing specific health issues and improving quality of life. This may include surgical interventions for congenital heart defects, supportive therapies for feeding difficulties or developmental delays, and regular medical monitoring. The prognosis varies widely depending on the extent of mosaicism and the severity of symptoms, with many affected individuals facing significant health challenges.
Clinical Advice & FAQs
Billing Guidance
Is Q91.1 a billable ICD-10 code?
Yes, Q91.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q91.1?
Clinical documentation must specify the nature of Trisomy 18, mosaicism (mitotic nondisjunction) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference